by Elena Iemma | Jun 8, 2022 | Featured, Recipes for Success - Vlog
On this installment of Recipes for Success, Annie and Katie sit down to talk with Meena Subramanyam, VP, Global Program Leader and Conditional T cell Engager Platform Lead at Takeda Oncology. Meena attended the EpiVax Women in Biotech Summit that we hosted in New York...
by Elena Iemma | May 26, 2022 | Featured, Thinking Out Loud -Blog
Monkeypox, Avian Influenza and Q Fever, Oh My! Before getting to other news, we share your sorrow and horror over the lives lost in Texas this week and agree that common sense gun legislation is long overdue in the USA. EpiVax team members are appalled and saddened...
by Elena Iemma | May 25, 2022 | Featured, News
PROVIDENCE, RI, May 25, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication “Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity” in Frontiers in Immunology, a collaboration...
by Elena Iemma | May 18, 2022 | Events, Featured
Thank you to our wonderful speakers and attendees who made this such a great inaugural seminar! Stay tuned for news on the 2023 event! Scroll down to see photos from the day. Organizing Theme: Activation of Regulatory T Cells for Induction of Immune Tolerance...
by Elena Iemma | May 5, 2022 | Events, Featured
The EpiVax team is excited to in-person at AAPS NBC 2022 in Anaheim, CA! Interested in connecting? Consider stopping by one of our presentations, or say hello to our team at Booth #301 in the exhibit hall! Additionally, you can request a meeting through the Connect360...
by Elena Iemma | Apr 26, 2022 | Featured, Thinking Out Loud -Blog
Do you need a COVID Booster? Take a look at this headline: “Scientists Demand FDA Recognize T cells”. The article is on behalf of the poor, neglected T cell that is doing all the work behind the scenes driving protective immunity. Why do we care?...